Avery Dennison Labels & Packaging Materials Europe has developed S788P, a new adhesive that enhances security for pharmaceutical box packaging.
The new permanent emulsion acrylic adhesive is also designed to protect both the package and labels from tampering.
Compared to other adhesives, the new material possesses twice the internal strength and ensures successful fibre tear if an applied pharmaceutical label is removed from various card and varnished surfaces.
Avery Dennison Materials Group Europe pharma and healthcare global segment director Ricardo ten said: “The World Health Organisation (WHO) has previously estimated that up to 10% of medicines across the globe are counterfeit.
“It no longer gives a figure, but says that counterfeiting can involve large scale manufacturing, and affects every country. Product protection remains a critically important issue for anyone working in the pharma segment.
“Avery Dennison has a very wide pharma security portfolio designed to leave visual signs on the pharmaceutical box, with both label damage or box damage options.”
The company noted that they will also help converters and their customers to meet new regulations for pharma packaging.
The S788P adhesive is said to comply with the EU's new falsified medicines directive 2011/62/EU, which has mandated the use of tamper-evident labelling.
Avery Dennison, which provides labelling and packaging materials and solutions, currently has operations in more than 50 countries.
The company recently launched two new solutions under its flexible packaging portfolio.
Image: Avery Dennison creates new tamper-evident adhesive S788P. Photo: courtesy of Avery Dennison.